Pharma News

pharma courses

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • Cancer fingerprint can improve early detection
    11 December 2024

    Cancer fingerprint can improve early detection

    Different types of cancer have unique molecular ‘fingerprints’ which are detectable in early stages of the disease and can be picked up with near-perfect accuracy by small, portable scanners in just a few hours, according to a study published today in the journal Molecular Cell.

  • 11 December 2024
    NIH Study Finds Tecovirimat Was Safe but Did Not Improve Mpox Resolution or Pain

    The antiviral drug tecovirimat did not reduce the time to lesion resolution or have an effect on pain among adults with mild to moderate clade II mpox and a low risk of developing severe disease, according to an interim data analysis from the international clinical trial called the Study of Tecovirimat for Mpox (STOMP). There were no safety concerns associated with tecovirimat.

  • 11 December 2024
    PAHO highlights increase in dengue, Oropouche, and avian influenza cases in the Americas
    The Pan American Health Organization reported on three transmissible diseases affecting the Region of the Americas: dengue, Oropouche, and avian influenza. PAHO Director Dr. Jarbas Barbosa expressed concern over the increase in cases in 2024 but emphasized effective strategies to control the outbreaks and mitigate their impact.
  • 11 December 2024
    Suven to acquire controlling stake in NJ Bio Inc.

    Suven Pharmaceuticals Limited a technology-leading CDMO specializing in complex and innovative drug modalities, has announced the acquisition of a controlling stake in NJ Bio Inc. with an investment of  USD 64.4 million.

  • 9 December 2024
    New drug tested to reduce side effect of ‘half-matched’ stem cell transplants
    Stem cell transplantation, using devices like the one shown here, is used to treat several types of blood cancers, but carries the risk of a life-threatening side effect called graft-versus-host disease. Results from a clinical trial conducted by researchers at WashU Medicine showed adding the investigational drug itacitinib to standard care for half-matched stem cell transplantation may reduce rates of the disease, in which the donor’s stem cells attack the patient’s healthy tissues.
  • 9 December 2024
    Wearable devices can help predict five year risk of falls for people with Parkinson’s Disease
    Falls are a common problem for people living with Parkinson’s. A recent review estimated that some 60% of all people living with PD have experienced at least one fall. These can lead to injury and hospitalisation, as well as reduced mobility, quality of life, and life expectancy.
  • 9 December 2024
    Network-based analyses uncover how neuroinflammation-causing microglia in Alzheimer’s disease form

    Cleveland Clinic Genome Center researchers have unraveled how immune cells called microglia can transform and drive harmful processes like neuroinflammation in Alzheimer’s disease. The study, published in Alzheimer’s & Dementia: The Journal of The Alzheimer’s Association, also integrates drug databases with real-world patient data to identify FDA-approved drugs that may be repurposed to target disease-associated microglia in Alzheimer’s disease without affecting the healthy type. 

  • 5 December 2024
    Cosmetics Science Convergence 2024

    Cosmetics Science Convergence 2024, a Conference on Building Multidisciplinary Networks to Drive Science & Technology in cosmetics was organized by JSS, division of Cosmetics science, School of life science, Mysuru, Karnataka, India from 2nd to 3rd December 2024.

  • 5 December 2024
    Natural Biopesticide Against Malaria Mosquitoes Successful in Early Field Tests

    An experimental bacteria-derived biopesticide is highly effective in killing malaria-carrying mosquitoes, including those that have developed resistance to chemical pesticides, according to initial field tests led by researchers at the Johns Hopkins Bloomberg School of Public Health.

  • 5 December 2024
    New method offers insights into Alzheimer’s mechanisms and potential drug targets

    Researchers at Columbia University Mailman School of Public Health have developed a novel computational pipeline designed to identify protein biomarkers associated with complex diseases, including Alzheimer’s disease (AD). This innovative tool analyzes biomarkers that can induce 3D structural changes in proteins, providing critical insights into disease mechanisms and highlighting potential targets for therapeutic intervention.

Subscribe to Pharma News